Industry Leaders
-
The New Regulations: Will They Hurt Your Business?
2/1/2015
Accurate and timely safety/ pharmacovigilance (PV) reporting is required to avoid embarrassing Warning Letters and potentially huge fines and penalties.
-
Precision Oncology: Big Data And Analytics Come To Cancer Care
12/24/2014
Cancer care is creating a new era of precision oncology. Profiling the molecular alterations in a patient’s tumor can identify changes that correlate with likely response or resistance to particular therapies. This type of molecular profiling also can lead to more precise treatment, replacing historical “one-size-fits-all” approaches.
-
Approaches To Comparative Effectiveness Research
12/7/2010
The outcomes and costs associated with medical innovations are of increasing interest. Randomized clinical trials are the standard for determining if a therapy is safe and efficacious, but may not reflect real world treatment effectiveness. The evidence gap between clinical trials and studies of effectiveness is gaining importance.
-
Improving Global Health Through Advances In Pharmaceutical Sciences
12/7/2010
The future success of our industry will largely depend on our ability to cooperate internationally. The face of our industry is changing, and although this may present a number of short-term challenges, the change is for the better — it does present a wealth of opportunities in areas previously underserved or in some cases not served at all.